PDCD1 and neoplasm: In this study, we used an in vivo CRISPR-Cas9 knockout screen in a murine cancer model to identify phosphatidylserine (PS) synthase 1 (Ptdss1) as an additional intrinsic regulator of tumor cell fitness under anti–PD-1–selective pressure.